ME 3407
Alternative Names: EF 4040Latest Information Update: 01 Jun 1995
At a glance
- Originator Meiji Seika Kaisha
- Class Antisecretories; Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 01 Jun 1995 Discontinued-II for Peptic ulcer in Japan (Unknown route)
- 16 Mar 1995 Phase-II clinical trials for Peptic ulcer in Japan (Unknown route)